The historic 21st Century Cures Act, written into law last December, is a 362-page bill comprised of several initiatives impacting the life sciences industry. The allocation of $4.8 billion for the “Cancer Moonshot” portion of the bill won over most headlines during...
The culture of sharing and openness in the clinical trial data arena is improving – for sure, it’s being talked about. Large pharma and pharma associations are making pledges to make data collected more available. They are being careful to limit disclosure such that...
According to an editorial published in the January edition of the British Medical Journal, researchers often do not report relevant clinical trial data. The editorialists said the problem is missing data, “We are not dealing here with trial design, hidden bias or...
